A funding round has pulled in $7 million for Daktari Diagnostics, a Cambridge, Mass.-based maker of diagnostic tests for tuberculosis, HIV and hepatitis. The funding follows the firm's recent announcement that it will expand its business into Scotland with its HIV blood-monitoring tool and add 126 new jobs there.